We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+11.39%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$634M
AUM Growth
+$113M
Cap. Flow
+$79.5M
Cap. Flow %
12.54%
Top 10 Hldgs %
42.47%
Holding
197
New
65
Increased
36
Reduced
30
Closed
49

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$25.1M
2
AMZN icon
Amazon
AMZN
+$13.4M
3
SNPS icon
Synopsys
SNPS
+$8.98M
4
KNX icon
Knight Transportation
KNX
+$8.3M
5
AMRS
Amyris Inc.
AMRS
+$8.01M

Sector Composition

Rank Sector Weight
1 Technology 29.88%
2 Healthcare 13.86%
3 Industrials 10.8%
4 Consumer Discretionary 4.6%
5 Consumer Staples 4.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDNW
51
RideNow Group
RDNW
$255M
$1.96M 0.31%
21,850
+4,915
+29% +$463K
NOW icon
52
ServiceNow
NOW
$117B
$1.93M 0.3%
35,000
+15,000
+75% +$788K
CELG
53
DELISTED
Celgene Corp
CELG
$1.84M 0.29%
19,900
-264,600
-93% -$25.1M
ITRI icon
54
Itron
ITRI
$4.55B
$1.72M 0.27%
27,500
+17,500
+175% +$972K
HCA icon
55
HCA Healthcare
HCA
$90.9B
$1.49M 0.23%
11,000
+5,000
+83% +$632K
TTOO
56
DELISTED
T2 Biosystems, Inc
TTOO
$1.47M 0.23%
175
+10
+6% +$117K
BSX icon
57
Boston Scientific
BSX
$67.5B
$1.42M 0.22%
33,000
+10,500
+47% +$404K
GNRC icon
58
Generac Holdings
GNRC
$12B
$1.39M 0.22%
+20,000
New +$1.17M
CQQQ icon
59
Invesco China Technology ETF
CQQQ
$3.01B
$1.36M 0.21%
+30,000
New +$1.41M
TMO icon
60
Thermo Fisher Scientific
TMO
$216B
$1.32M 0.21%
+4,500
New +$1.24M
ABT icon
61
Abbott
ABT
$190B
$1.26M 0.2%
15,000
+4,500
+43% +$354K
WDAY icon
62
Workday
WDAY
$41.1B
$1.23M 0.19%
+6,000
New +$1.21M
SYK icon
63
Stryker
SYK
$135B
$1.23M 0.19%
6,000
+1,500
+33% +$286K
GWRS icon
64
Global Water Resources
GWRS
$216M
$1.22M 0.19%
117,000
CRUS icon
65
PUT
Cirrus Logic
CRUS
$6.79B
$1.09M 0.17%
+25,000
New +$1.09M
CWEN.A
66
DELISTED
Clearway Energy Class A
CWEN.A
$968K 0.15%
60,000
+5,000
+9% +$75.8K
META icon
67
PUT
Meta Platforms (Facebook)
META
$1.49T
$965K 0.15%
5,000
ENS icon
68
EnerSys
ENS
$6.63B
$960K 0.15%
+14,000
New +$915K
LLY icon
69
Eli Lilly
LLY
$1.09T
$942K 0.15%
8,500
+3,500
+70% +$412K
LITE icon
70
Lumentum
LITE
$48.4B
$935K 0.15%
17,500
+12,500
+250% +$666K
VRTX icon
71
Vertex Pharmaceuticals
VRTX
$125B
$917K 0.14%
+5,000
New +$874K
CNR
72
DELISTED
Cornerstone Building Brands, Inc.
CNR
$904K 0.14%
+155,000
New +$861K
SBUX icon
73
PUT
Starbucks
SBUX
$119B
$838K 0.13%
+10,000
New +$784K
ZBH icon
74
Zimmer Biomet
ZBH
$18.7B
$824K 0.13%
+7,210
New +$844K
ADI icon
75
Analog Devices
ADI
$175B
$790K 0.12%
+7,000
New +$758K

Similar funds

Ardsley Advisory Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Ardsley Advisory Partners held 197 positions worth $634M, up 22% from $521M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Ardsley Advisory Partners deployed $79.5M of net new capital in Q2 2019, opening 65 new positions and adding to 36 existing holdings. Its largest new stake was Organigram Holdings: 250,000 shares worth $6.44M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Celgene Corp, an estimated $25.1M trimmed.

  • Ardsley Advisory Partners's largest Q2 2019 buy was Organigram Holdings: 250,000 shares worth $6.44M.
  • Ardsley Advisory Partners added most to Walt Disney in Q2 2019, an estimated $17.1M increase.
  • Ardsley Advisory Partners's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $25.1M.
  • Ardsley Advisory Partners fully exited Amazon in Q2 2019, selling an estimated $13.4M.
  • Ardsley Advisory Partners's ten largest holdings make up 42% of its $634M portfolio in Q2 2019.
  • Ardsley Advisory Partners opened 65 new positions and closed 49 in Q2 2019.
  • Ardsley Advisory Partners's portfolio value rose 22% quarter-over-quarter to $634M.

Based on Ardsley Advisory Partners's 13F filing for Q2 2019, filed 13 Aug 2019.